Cannabis Suisse's EBIT is $-150K, below the sector sector average of $2.6T.
Get informed when a big investor buys or sells
+ FollowAs of May 31, 2026
Trailing 12 months ending May 31, 2026
Cannabis Suisse (CSUI) currently reports a EBIT of $-150K as of May 2026. That compares with $-510K in the prior-year period — up 69.8% year over year. That is below the sector sector average of $2.6T. Use the charts on this page to explore Cannabis Suisse's EBIT history and peer comparisons.
Cannabis Suisse's EBIT increased from $-510K to $-150K — a 69.8% year-over-year increase (period ending May 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Cannabis Suisse's EBIT of $-150K is lower than the its sector sector average of $2.6T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
Cannabis Suisse reported $-150K in EBIT as of May 2026. That compares with $-510K in the prior-year period — up 69.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current EBIT of $-150K, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.6T. From there, open related valuation or income-statement pages for Cannabis Suisse, and consider following CSUI for alerts when major investors trade the stock.